Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Mar 9;15(3):e0229946. doi: 10.1371/journal.pone.0229946

Oral health treatment habits of people with schizophrenia in France: A retrospective cohort study

Frédéric Denis 1,2,3,*, Karine Goueslard 4,5, Francesca Siu-Paredes 6,7, Gilles Amador 2, Emmanuel Rusch 1, Valérie Bertaud 8,9, Catherine Quantin 4,5,10,11
Editor: Denis Bourgeois12
PMCID: PMC7062238  PMID: 32150582

Abstract

Objective

To identify the differences between persons with schizophrenia (PWS) and general population in France in terms of oral health treatment (tooth scaling, dental treatment and tooth extraction) and the factors associated with these differences.

Methods

This retrospective cohort study included PWS identified from a representative sample of 1/97th of the French population (general sample of beneficiaries). PWS were identified from 2014 data by an algorithm that included: F2 diagnostic codes in the register of long-term diseases in 2014 AND {(at least three deliveries of antipsychotics in 2014) OR (F20 diagnostic codes as a main or associated diagnosis in hospital discharge abstracts in 2012 or 2013 (hospital data for medicine, surgery and obstetrics)}. Follow-up dental care was explored for all people over a period of 3 years (2014 to 2017).

Results

In 2014, 580,219 persons older than 15 years were identified from the 96 metropolitan departments in France; 2,213 were PWS (0.4%). Fewer PWS were found along a diagonal line from north-east to south-west France, and the highest numbers were located in urban departments. PWS were more often male (58.6% vs 48.7%, p<0.001). They were less likely to have had tooth scaling but more likely to have undergone a dental extraction. In one third of departments, more than 50% of PWS had at least one tooth scaling over a three-year period; the rate of dental extraction in these departments ranged from 6 to 23%. Then, a quarter of the departments in which 40 to 100% of PWS had had at least one dental extraction (2/8) presented a rate of tooth scaling ranging from 0 to 28% over the study period.

Conclusions

Compared with the general population, PWS were less likely to have had tooth scaling and dental treatment but more likely to have undergone dental extraction.

Introduction

Schizophrenia affects between 0.7 and 1% of the worldwide population and 400 000 to 600 000 individuals in France [1]. This mental illness is a severe psychiatric disorder characterized by significant cognitive and emotional disruptions. Schizophrenia requires long-term medical treatment, which can result in physical, psychological, and social problems related to both the disease and the potential side effects of treatment [2]. The negative symptoms of schizophrenia, such as lack of initiation, a lack of concern for personal health, social withdrawal and a lack of motivation, may lead persons with schizophrenia (PWS) to neglect their self-care resulting in higher rates of physical ill-health [3,4]. Studies show that 19 to 57% of PWS have at least one associated somatic condition, including cardiovascular, gastrointestinal, respiratory, neoplastic, infectious, endocrine, and oral disorders. Furthermore, these persons suffer from stigmatization and inequities in terms of access to treatment, and thus about half of these comorbidities remain undiagnosed [58]. Excess mortality rates due to the complications of a chronic physical illness are two or three times higher in such patients than in the general population, resulting in a 10 to 25-year reduction in life expectancy in comparison with the rest of the population [910].

The trend towards poor physical health in people with mental illness has been the subject of growing attention [11,12], but there has been less interest in the issue of oral health [1315]. Nevertheless, oral health is an important part of overall physical condition. In their original review on this topic, Kisely et al. reported the reasons for poor oral health in persons with severe mental illness, including PWS, and its impact on general health [16]. Specifically, dental caries and periodontal measurement indexes often reach twice the level found in the general population [1719]. A number of combined factors contribute to the poor oral health of these individuals. These factors can include orales infectious diseases interacting with metabolic disturbances induced by antipsychotic treatments (diabetes, obesity), and also poor diet and lifestyle behaviors (high-sugar diet, use of psychoactive substances such as tobacco, and inadequate oral hygiene) [2022]. Finally, poor oral health impacts social functioning and affects quality of life, self-esteem and self-confidence, which are already dramatically lower in this population [16,23].

In the French department of Côte d’Or (530,000 inhabitants), a previous study was conducted with PWS, using a random stratified method. This study showed that, compared with data available for the general population, there were more extractions and missing teeth and fewer dental fillings [24]. But this study was limited to one area of France and was based on data from volunteers, who may differ from the target population. Furthermore, the most recent available data on oral health epidemiology and for the general population are more than 20 years old [25].

Our aim was to identify the differences between PWS and general population in France in terms of oral health treatment (tooth scaling, dental treatment and tooth extraction) and the factors associated with these differences.

Materials and methods

Design of the study and sample of the population

This retrospective cohort study focused on PWS identified from a representative sample of 1/97th of the French population that is known as the EGB (echantillon généraliste de bénéficiaires, general sample of beneficiaries). Follow-up dental care was explored for all people in the EGB over a period of 3 years (2014 to 2017).

The EGB was constructed on a national level by the French health insurance agency, which manages the representativeness of the data. It was drawn randomly from a check digit of the beneficiary’s identification number. From a stable, representative sample of the French population, these data allowed us to estimate care pathways and follow-up while excluding the effects of the geographical area, health facility or practices. The EGB was based on the “National System of Health Data” (SNDS) database which collects individual hospital and non-hospital healthcare data. These data include automatically recorded healthcare acts such as biological testing, treatment, medical transport and a register for long-term diseases. Health insurance is compulsory for everyone living in France, and each health act is reimbursed by the French health insurance agency and therefore recorded in SNDS. These data include all types of mandatory health insurance systems (the main national health insurance, health insurance for the agricultural sector, health insurance for the self-employed and 12 other specific health insurance schemes) covering more than 90% of the French population. In 2016, the EGB sample was made up of almost 600,000 health insurance beneficiaries. The reliability of the SNDS has been established in recent studies [26,27].

Groups constitution

Persons with schizophrenia identification

PWS were identified for the year 2014 by an algorithm that included:

  • Diagnostic Codes F2 in the register of long-term diseases [28] in 2014 AND {(at least three deliveries of antipsychotics in 2014) OR (Diagnostic codes F20 as a main or associated diagnosis in hospital discharge abstracts in 2012 or 2013 (hospital data for medicine, surgery and obstetrics)}

The purpose of this algorithm was to identify adult schizophrenia in the SNDS database. It was built using the information obtained from interviews with experts in schizophrenia and based on their procedures to identify in- or out-patients [29].

Control identification

The control group was composed of all the people who are included in the EGB and not included in the cohort of patients with schizophrenia.

Because the diagnosis of schizophrenia is rare and difficult before age 15 years [30], we only recruited individuals over 15 years old.

Outcomes

Variables

The main outcomes of interest (in the French Common Classification of Procedures) were; 1) tooth scaling (code HBJD001); 2) dental treatments (codes HBMD0-, HBFD0-); and 3) tooth extraction (code HBGD0-) [31]. These 3 outcomes are covered by French National Insurance.

  1. Tooth scaling is a common dental cleaning procedure to remove plaque buildup. Tooth scaling prevents periodontal disease. It is the most common procedure in general dentistry.

  2. Dental treatments were all procedures for filling cavities, root canal treatments, such as exeresis of canal content, or exeresis of pulp, tooth restoration, and denture-repair.

  3. Tooth extractions were identified by their location in the mouth, i.e. avulsion of canine tooth, ectopic tooth, or molar tooth.

The outcomes of interest were explored as qualitative variables: binary (at least one dental treatment) or nominal variables with more than 2 categories (1, 2–3 or >3).

The explanatory variables were age and gender; these variables were assessed in the group of patients with schizophrenia and the group without schizophrenia.

Statistical analysis

Qualitative variables were expressed as percentages and were first compared between the two groups with and without schizophrenia using the Fisher exact test, under the conditions of application. The number and percentage of dental acts weres presented by class (1, 2–3, or >3) for each type of care.

Geographic analysis

The geographic scale used for this analysis was the geographic department code recorded in the EGB. France is divided into 96 metropolitan departments, with populations ranging from 77,000 to 2,577,000 inhabitants.

Mapping of population and distribution of dental care

For each department of residence, the size of the symbol varied proportionally with the number of people with schizophrenia who resided there. Access to each type of dental care was calculated by plotting the number of overall PWS against the number of patients receiving dental care. The rate of dental care was expressed as a percentage for each category.

Multivariate logistic regressions analyses

To estimate the association between schizophrenia and dental outcomes, multivariate logistic regressions and multivariate logistic regressions adjusted for sex were performed by age category (15–24, 25–34, 35–44, 45–54, 55–64, ≥65). The results are reported as adjusted odds ratios (aOR) with 95% confidence intervals (CI).

Two sensitivity analyses were performed for other algorithms.

First, we identified PWS from an algorithm used by the National Institute for Health Surveillance (InVS) [32] in order to estimate the prevalence of schizophrenia in France:

  • F20 diagnostic codes in the register of long-term diseases associated with the F20 codes as the main or associated diagnoses in discharge abstracts (hospital data for medicine, surgery and obstetrics and/or psychiatry)

  • And/or at least three annual deliveries of antipsychotics in 2014 associated with the F20 ICD-10 codes as the main or associated diagnoses in discharge abstracts (hospital data for medicine, surgery and obstetrics and/or psychiatry) over the past four years.

Our algorithm did not include data from psychiatric hospitals.

Second, we identified PWS with a less restrictive algorithm, including the presence of

  • one of the F20 diagnostic codes in the register for long-term diseases,

  • and/or one of the F20 diagnostic codes as the main or associated diagnoses in discharge abstracts (hospital data for medicine, surgery and obstetrics),

  • and/or at least three annual deliveries of antipsychotics in 2014.

A p-value of 0.05 was set to define statistical significance for all analyses. SAS 9.3 software was used for data analyses. The geographic information system MapInfo 11.0 was used for mapping.

Ethical approval

French university hospital researchers have a permanent authorization to manage data from the EGB as indicated in the Decree n° 2016–1871 of December 26, 2016 on processing of personal data from SNDS. Data was treated by individuals who were authorized by the State. This study was conducted in accordance with the Declaration of Helsinki. Individual written consent was not needed for this study.

Results

Population and distribution of dental care

In 2014, 580,219 persons over 15 years old were identified in EGB. Among them, 2,213 PWS (0.4%) were identified by our algorithm.

Every department in metropolitan France presented at least one case of schizophrenia in 2014. The departments located along a diagonal line from the north-east to the south-west had fewer cases of schizophrenia, while the highest numbers were in urban departments, those bordering the Mediterranean, and along the external borders (Fig 1).

Fig 1. Geographical distribution of persons with schizophrenia.

Fig 1

Our comparison found a significant difference between PWS and persons without schizophrenia in terms of age and gender (Table 1).

Table 1. Population and distribution of dental care.

With schizophrenia (n = 2.213) % Without schizophrenia (n = 578,006) % p-value
Age
15–24 74 3.3 87,994 15.2
25–34 339 15.3 96,254 16.7
35–44 572 25.9 97,262 16.8 <0.001
45–54 525 23.7 97,291 16.8
55–64 428 19.3 85,459 14.8
≥65 275 12.4 113,746 19.7
Gender
Male 1,297 58.6 281,434 48.7 <0.001
Female 916 41.4 296,572 51.3
Tooth scaling 919 41.5 277,206 48.0 <0.001
1 280 12.7 90,152 15.6
2–3 415 18.8 126,494 21.9 <0.001
>3 223 10.1 60,560 10.5
Dental treatments 927 41.9 242,809 42.0 0.91
1 194 8.8 67,973 11.8
2–3 323 14.6 84,637 14.6 <0.001
>3 410 18.5 90,199 15.6
Tooth extraction 503 22.7 106,108 18.4 <0.001
1 307 13.9 71,359 12.4
2–3 154 7.0 30,330 5.2 <0.001
>3 42 1.9 4.419 0.8

*Fisher exact test

PWS were more often male (58.6% vs 48.7%, p<0.001) and more likely to be aged 35 to 64 years.

PWS were less likely to have tooth scaling and more to have dental extraction during the 3-years follow-up period. The overall rate of tooth scaling was 41.5% for PWS and 48.0% for people without schizophrenia (p<0.0001). In PWS, the rate of tooth scaling decreased with age. There was a significant difference in the frequency of tooth extraction between the two groups: 22.7% of PWS had had at least one dental extraction versus 18.4% of people without schizophrenia (p<0.0001). The spatial distribution of tooth scaling (Fig 2), dental treatment (Fig 3) and tooth extraction (Fig 4) appeared to be random. In one third of departments, more than 50% of PWS had at least one recorded tooth scaling over the three-year period.

Fig 2. Geographical distribution of scaling tooth rate for persons with schizophrenia.

Fig 2

Fig 3. Geographical distribution of dental treatment rate for persons with schizophrenia.

Fig 3

Fig 4. Geographical distribution of tooth extraction rate for persons with schizophrenia.

Fig 4

In these same departments, the rate of dental extractions ranged from 6 to 23%. In eight departments, at least one dental extraction was recorded for 40 to 100% of PWS. A quarter of these departments (2/8) reported a rate of tooth scaling ranging from 0 to 28% over the study period.

Multivariate logistic regressions analysis

The results of adjusted logistic regression analyses within 3 years are presented in Table 2.

Table 2. Multivariate logistic regressions analysis.

Age category 15–24 25–34 35–44
OR IC 95% p OR IC 95% p OR IC 95% p
Tooth scaling
CG 1.05 0.65–1.67 0.85 1.24 0.99–1.54 0.05 0.95 0.80–1.11 0.5
Gender 1.45 1.41–1.49 <0.0001 1.66 1.62–1.70 <0.0001 1.53 1.49–1.57 <0.0001
Dental extraction
CG 2.05 1.18–3.57 0.01 1.82 1.40–2.37 <0.0001 1.53 1.26–1.87 <0.0001
Gender 1.31 1.26–1.37 <0.0001 1.04 101–1.08 0.04 1.01 0.97–1.04 0.75
Dental treatment
CG 1.34 0.83–2.17 0.22 1.42 1.15–1.76 0.001 1.11 0.94–1.31 0.21
Gender 1.24 1.20–1.27 <0.0001 1.30 1.27–1.33 <0.0001 1.30 1.27–1.34 <0.0001
Age category 45–54 55–64 ≥65
OR IC 95% p OR IC 95% p OR IC 95% p
Tooth scaling
CG 0.63 0.53–0.75 <0.0001 0.45 0.37–0.55 <0.0001 0.42 0.32–0.57 <0.0001
Gender 1.52 1.48–1.56 <0.0001 1.48 1.44–1.52 <0.0001 1.17 1.14–1.19 <0.0001
Dental extraction
CG 1.39 1.15–1.69 0.001 0.87 0.70–1.10 0.25 0.82 0.61–1.11 0.19
Gender 0.97 0.94–1.00 0.05 0.98 0.95–1.01 0.11 0.93 0.90–0.95 <0.0001
Dental treatment
CG 0.84 0.71–1.00 0.05 0.63 0.52–0.77 <0.0001 0.7 0.54–0.89 0.005
Gender 1.26 1.23–1.30 <0.0001 1.23 1.20–1.23 <0.0001 1.06 1.03–1.08 <0.0001

OR: odds radio; CI: Confidence Interval; CG: Control group; Gender (ref = male)

Between 15 and 44 years, schizophrenia was not significantly associated with tooth scaling after adjustment for sex. Regression logistic analysis showed that schizophrenia was associated with decreased frequency of tooth scaling from the age of 45 years (aOR = 0.45 95% CI [0.37–0.55] for age 55–64 years). Schizophrenia was significantly associated with a higher frequency of dental treatment for 25–34 year olds (aOR = 1.42[1.15–1.76]) and a decreased frequency of dental treatment after 55 years (aOR = 0.63 95% CI [0.52–0.77] for age 55–64 years). Then, schizophrenia was associated with an increased risk of dental extraction in patients 15 to 54 years old. The presence of schizophrenia yielded an aOR of 2.05 (95% CI 1.18–3.57) for youths aged 15 to 24. After 55 years, the risk of dental extraction was not significant. Female gender was associated with more frequent tooth scaling and dental treatment, regardless of age.

Discussion

To our knowledge, this study is the first to use national data to analyze the oral health treatment habits of PWS based on a large representative sample (2,213).

We highlighted certain disparities between the oral health treatment trends for PWS and for the general population. These disparities include both the type and frequency of care on a national scale.

It is well known that regular professional tooth cleaning is important for the prevention of dental caries and periodontal disease [33]., In addition, though the “Haute Autorité de Santé” suggested regular monitoring of oral health in 2010 [34], annual tooth scaling has only been recommended in France since 2013–2014 [35]. PWS seem to have more difficulty accessing the benefits provided bythe National Health Insurance program, leading to inadequate dental care (less tooth scaling and more dental extraction) [13,24,36]. This could explain why PWS access oral health care less frequently and have worse dental health than the general population.

The social and psychological impact of dental extractions can have significant consequences on quality of life [13,37]. The basic ability to chew food can also be affected. Tooth Extraction may be a quick-fix solution to pain and discomfort but there are benefits to saving and restoring dentition [3739].

Compared with other types of medical care, dental visits are widely underutilized by PWS, which means that dental treatment should be delivered in a more preventive manner [40]. The disparities in preventive care between PWS and the general population may also be due to the difficulties faced by PWS when accessing and using health services [39,40]. For instance, dentists are more likely consider these patients as “difficult to manage”, which may lead to them to opt for simple tooth extractions, foregoing the more complicated methods. Such practices or behavior may result in cases of “early missing teeth” [41]. Schizophrenia may severely interfere with patients seeking dental treatment, delaying restorative treatment until tooth loss is inevitable. Moreover, studies have shown that dental health is often seen as lower priority in the global health approach of PWS [42,43].

The results of the multivariate logistic regressions analysis shows that PWS who are male or older were especially likely to have less tooth scaling and more dental extraction. On the contrary, women generally had more positive oral health attitudes and practices (using extra cleaning devices for example) [44,45]. In a population of institutionalized psychiatric patients, Ngo DY et al. [46] also found that males had more tooth decay than females. Compared with male patients, female patients may perceive a decayed tooth to be more problematic and report symptoms, meaning that they are more likely obtain dental care [46]. In an American study, dental health was linked to sex and socioeconomic status, and to a lesser extent to education and income, whereas age, race and dental insurance coverage were not significant [45]. Put simply, women are more likely than men to take care of themselves in daily life. Men therefore require additional encouragement to attend dental consultations.

Studies that have investigated age as contributing factor in tooth scaling or dental treatment are contradictory. Advanced age contributed to less frequent tooth brushing for Harada et al. [44], but other authors found no significant association [43]. Though elderly people often lose teeth as a result of periodontal disease and caries and there is an increase in tooth extractions with age, other factors such as education level and economic status are worth taking into account [47].

Recent international studies have showed that psychiatric inpatients lack sufficient preventive oral health care [3,1320], but this is the first study to highlight a gap in oral health treatment in PWS in France, and we describe the obvious disparity in consumption that underlies poor oral health. These results also appear to be generally compatible with reports from the literature related to the oral health of PWS [15,19,34,43,46,47]. Dental ailments are largely preventable, and preventive measures such as daily tooth brushing and regular dental checkups are simple and easy to implement [48]. In contrast, the combination of poor diet and lifestyle behaviours (high-sugar diet, use of psychoactive substances such as tobacco, and inadequate oral hygiene lead to poor health [3,16,17]. The future development, testing and implementation of interventions to improve oral health in PWS can be guided by the present findings, which provide important data regarding shortcomings in treatment and the need for more regular dental visits in this population.

Limitation and strengths

The algorithm used to identify PWS did not include the database of psychiatric hospitalizations even though it was included in the reference algorithm. This is because the EGB does not include the French psychiatric database. However, the persons who were covered as part of long-term disease with diagnostic codes F20- represent approximately 70% of people identified by the SNDS as suffering from psychotic disorders.

Furthermore, this bias is probably of limited effect. The potential consequence would be an inclusion of unidentified cases of schizophrenia in the control group, therefore reducing the amplitude of the reported associations.

One of the strengths of our study is the representativeness of the EGB of the French general population and its high stability over time. An additional strength is the fact that health insurance is compulsory for all French residents. This means that all health care acts are reimbursed, and all reimbursements are automatically recorded and transferred to the SNDS database. The quantification of dental care can therefore be considered exhaustive.

Moreover, our results suggest a spatial prevalence of schizophrenia that is tied to urbanicity. Urbanicity is a well-established environmental risk factor for developing schizophrenia [49], and the prevalence of schizophrenia is known to be greater in cities than in rural areas [49,50].

In accordance with a number of published studies, our PWS sample was predominantly male [51]. However, patients were more likely to be aged 35 to 64 even though the initial symptoms of schizophrenia often begin before 20 years of age [52]. It is possible that mental illness was often undiagnosed in the early stages or that the algorithm used in our study was not accurate enough. It is known that untreated psychosis in first-episode cases means that patients are often actively psychotic for a very long time before they get help [53]. For this reason, we cannot rule out a number of unidentified PWS in our study.

Conclusion

This is the first study to provide geographic mapping of the oral health treatment of PWS in France. We found that the departments located along a north-east/south-west diagonal line had fewer PWS while the highest number were in urban departments, those bordering the Mediterranean, and along the external borders. We highlighted that PWS were less likely to have had tooth scaling and dental treatments but more likely to have undergone a dental extraction than general population. We noticed a clear inequity in oral health treatment, and national health policies are needed to address this issue. Further studies are needed in order to improve the management of oral health in PWS, potentially with the use of specific prevention and education programs. But first of all, the most pressing challenge is to expand the understanding of the factors that limit or facilitate the healthcare pathway for PWS in order to optimize their oral health.

Acknowledgments

The authors are grateful to Suzanne Rankin for revising the manuscript

Data Availability

The database was transmitted by the National Health Insurance Fund for Salaried Workers-CNAMTS (Caisse nationale de l'assurance maladie des travailleurs salaries; address: Caisse Nationale de l’Assurance Maladie 50 Avenue du Professeur André Lemierre, 75020 Paris) (responsible for the extraction of EGB data). The use of these data by our department was approved by the National Committee for data protection. Data used in this study are available for researchers who meet the criteria for access to these French data from the National Health Insurance Fund (training that open a personal accreditation, approval of the protocol by required authorities (Expert Committee to researches, studies and evaluations in the health field-CEREES, and National Committee for data protection-CNIL) according to the “Décret n° 2016-1872 du 26 décembre 2016 modifiant le décret n° 2005-1309 du 20 octobre 2005 pris pour l’application de la loi n° 78-17 du 6 janvier 1978 relative à l’informatique, aux fichiers et aux libertés”, https://www.legifrance.gouv.fr/eli/decret/2016/12/26/2016-1872/jo/texte. A permanent access is granted to some public services within the limits established by laws (Décret n° 2016-1871 du 26 décembre 2016 relatif au traitement de données à caractère personnel dénommé « système national des données de santé », https://www.legifrance.gouv.fr/eli/decret/2016/12/26/2016-1871/jo/texte. Contact: Caisse Nationale de l’Assurance Maladie, 50 Avenue du Professeur André Lemierre, 75020 Paris

Funding Statement

The authors received no specific funding for this work

References

  • 1.Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci. 2000;250(6):274–285. 10.1007/s004060070002 [DOI] [PubMed] [Google Scholar]
  • 2.Kurtz MM, Wexler BE, Fujimoto M, Shagan DS, Seltzer JC. Symptoms versus neurocognition as predictors of change in life skills in schizophrenia after outpatient rehabilitation. Schizophr Res. 2008;102(1–3):303 10.1016/j.schres.2008.03.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Arnaiz A, Zumárraga M, Díez-Altuna I, Uriarte JJ, Moro J, Pérez-Ansorena MA. Oral health and the symptoms of schizophrenia.Psychiatry Res. 2011;30;188(1):24–8. [DOI] [PubMed] [Google Scholar]
  • 4.Vrbova K, Prasko J, Holubova M, Slepecky M, Ociskova M. Positive and negative symptoms in schizophrenia and their relation to depression, anxiety, hope, self-stigma and personality traits—a cross-sectional study.Neuro Endocrinol Lett. 2018;39(1):9–18. [PubMed] [Google Scholar]
  • 5.Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150:1115–21. 10.1016/j.ahj.2005.02.007 [DOI] [PubMed] [Google Scholar]
  • 6.Capasso RM, Lineberry TW, Bostwick JM, Decker P a., St. Sauver J. Mortality in schizophrenia and schizoaffective disorder: An Olmsted County, Minnesota cohort: 1950–2005. Schizophr Res. 2008;98:287–94. 10.1016/j.schres.2007.10.005 [DOI] [PubMed] [Google Scholar]
  • 7.Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Niskanen A, Haukka J. 11-year follow-up of mortality in patients with schizophrenia: a population-bases cohort study (FIN11 study). Lancet. 2009; 22;374(9690):620–7. 10.1016/S0140-6736(09)60742-X [DOI] [PubMed] [Google Scholar]
  • 8.Chafetz RNL, White RNMC, Collins-Bride RNG. The poor general health of the severely mentally Ill; impact of schizophrenic diagnosis. Community Ment Health J. 2005:41,169–184. 10.1007/s10597-005-2651-z [DOI] [PubMed] [Google Scholar]
  • 9.Oakley P, Kiseley S, Baxter A, Harris M, Desoe J, Dziouba A, et al. Increased mortality among people with schizophrenia and other nonaffective psychotic disorders in the community: A systematic review and meta-analysis. J Psychiatr Res. 2018: 102;245–253. 10.1016/j.jpsychires.2018.04.019 [DOI] [PubMed] [Google Scholar]
  • 10.Saha S, Chant D, McGrath J.A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64(10):1123–31. 10.1001/archpsyc.64.10.1123 [DOI] [PubMed] [Google Scholar]
  • 11.Monteleone P, Martiadis V, Maj M. Management of schizophrenia with obesity, metabolic, and endocrinological disorders. Psychiatr Clin North Am. 2009;32(4):775–94. 10.1016/j.psc.2009.08.003 [DOI] [PubMed] [Google Scholar]
  • 12.Montejo AL. The need for routine physical health care in schizophrenia. Eur Psychiatry. 2010;25 Suppl 2:S3–5. 10.1016/S0924-9338(10)71699-0 [DOI] [PubMed] [Google Scholar]
  • 13.Wey MC, Loh S, Doss JG, et al. The oral health of people with chronic schizophrenia: a neglected public health burden. Aust N Z J Psychiatry. 2016;50(7):685–694. 10.1177/0004867415615947 [DOI] [PubMed] [Google Scholar]
  • 14.Kisely S, Quek LH, Pais J, Lalloo R, Johnson NW, Lawrence D. Advanced dental disease in people with severe mental illness: systematic review and meta-analysis. Br J Psychiatry. 2011;199(3):187–93. 10.1192/bjp.bp.110.081695 Review. [DOI] [PubMed] [Google Scholar]
  • 15.Bertaud-Gounot V, Kovess-Masfety V, Perrus C, Trohel G, Richard F. Oral health status and treatment needs among psychiatric inpatients in Rennes, France: a cross-sectional study. BMC Psychiatry 2013, 13:227 10.1186/1471-244X-13-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kisely S, Baghaie H, Lalloo R, et al. A systematic review and meta-analysis of the association between poor oral health and severe mental illness. Psychosom Med. 2015;77(1):83–92. 10.1097/PSY.0000000000000135 [DOI] [PubMed] [Google Scholar]
  • 17.Thomas A, Lavrentzou E, Karouzos C, et al. Factors which influence the oral condition of chronic schizophrenia patients. Spec Care Dent. 1996;16(2):84–86. [DOI] [PubMed] [Google Scholar]
  • 18.Gurbuz O, Alatas G, Kurt E, et al. Oral health and treatment needs of institutionalized chronic psychiatric patients in Istanbul, Turkey. Community Dent Health. 2010;27(3):151–157. [PubMed] [Google Scholar]
  • 19.Ramon T, Grinshpoon A, Zusman S, Weizman A. Oral health and treatment needs of institutionalized chronic psychiatric patients in Israel. Eur Psychiatry. 2003; 18 (3), 101–105. 10.1016/s0924-9338(03)00023-3 [DOI] [PubMed] [Google Scholar]
  • 20.Denis Frederic, Pelletier Jean-François, Jean-Christophe Chauvet-Gelinier Nathalie Rude, Trojak Benoit.Oral health is a challenging problem for patients with schizophrenia: a narrative review. Iran J Psychiatry Behav Sci. 2018;12(1):e8062 10.5812/ijpbs.8062 Review. [DOI] [Google Scholar]
  • 21.Vancampfort D., Stubbs B., Michell A. J., et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14(3):339–347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kaye E K, Chen N., Cabral H. J., Vokonas P., Garcia R. I. Metabolic syndrome and periodontal disease progression in men. Journal of Dental Research. 2016;95(7):822–828. 10.1177/0022034516641053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Yang M, Chen P, He MX, Lu M, Wang HM, Soares JC, et al. Poor oral health in patients with schizophrenia: A systematic review and meta-analysis. Schizoph Res. 2018;18:30244. [DOI] [PubMed] [Google Scholar]
  • 24.Denis F, Milleret G, Wallenhorst T, Carpentier M, Rude N, Trojak B. Oral health in schizophrenia patients: A French Multicenter Cross-Sectional Study. Presse Med. 2019;48(2):e89–e99. 10.1016/j.lpm.2018.06.018 [DOI] [PubMed] [Google Scholar]
  • 25.Hescot P, Bourgeois D, Doury J. Oral health in 35–44 year old adults in France. Int Dent J. 1997;47(2):94–99. 10.1111/j.1875-595x.1997.tb00682.x [DOI] [PubMed] [Google Scholar]
  • 26.Lorgis L, Cottenet J, Molins G, et al. Outcomes after acute myocardial infarction in HIV-infected patients: analysis of data from a French nationwide hospital medical information database. Circulation 2013; 127:1767–74. 10.1161/CIRCULATIONAHA.113.001874 [DOI] [PubMed] [Google Scholar]
  • 27.Hanf M, Quantin C, Farrington P, et al. Validation of the French national health insurance information system as a tool in vaccine safety assessment: application to febrile convulsions after pediatric measles/ mumps/rubella immunization. Vaccine 2013;31:5856–62. 10.1016/j.vaccine.2013.09.052 [DOI] [PubMed] [Google Scholar]
  • 28.International Statistical Classification of Diseases and Related Health Problems. 10th Revision [Internet]. Geneva: Word Health Organization; 2010. [cited 2016 Dec 30]. Available from: http://apps.who.int/classifications/apps/icd/icd10online/
  • 29.Quantin C, Collin C, Frérot M, Besson J, Cottenet J, Corneloup M, et al. [Study of algorithms to identify schizophrenia in the SNIIRAM database conducted by the REDSIAM network]. Rev Epidemiol Sante Publique. 2017. Oct;65 Suppl 4:S226–S235. 10.1016/j.respe.2017.03.133 [DOI] [PubMed] [Google Scholar]
  • 30.Clemmensen L, Vernal DL, Steinhausen H-C. A systematic review of the long-term outcome of early onset schizophrenia. BMC Psychiatry 2012;12:150 10.1186/1471-244X-12-150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Recherche d'actes médicaux CCAM [Internet]. [cited 2019 May 08]. https://www.aideaucodage.fr/ccam
  • 32.Institut de Veille Sanitaire. Etalonnage du PMSI 2003 [Internet]. [cited 2019 May 08]. Available from: MCOhttp://opac.invs.sante.fr/doc_num.php?explnum_id=250
  • 33.Axelson P, Lindhe J., Nyström. On the prevention of caries and periodontal disease. Results of a 15‐year longitudinal study in adults. J Clin Periodontol. 1991. Mar;18(3):182–9. 10.1111/j.1600-051x.1991.tb01131.x [DOI] [PubMed] [Google Scholar]
  • 34.Haute autorité de santé: Stratégies de prévention de la carie dentaire 2010 [Internet]. [cited 2019 May 19]. Available from https://www.has-sante.fr/portail/upload/docs/application/pdf/2010-10/corriges_synthese_carie_dentaire_version_postcollege-10sept2010.pdf
  • 35.Union Française pour la Santé Bucco-dentaire: La Prevention Bucco-Dentaire En France un tournant à prendre 2012 [Internet]. [cited 2019 May 19]. Available from http://www.ufsbd.fr/wp-content/uploads/2014/06/Dossier-UFSBD-La-Pr%C3%A9vention-bucco-dentaire-en-France-un-tournant-%C3%A0-p-.pdf
  • 36.Chu K.-Y., Yang N.-P., Chou P., Chiu H.-J., Chi L.-Y., 2012. Comparison of oral health betweeninpatients with schizophrenia and disabled people or the general population. J. Formos. Med. Assoc. 111 (4), 214–219. 10.1016/j.jfma.2011.02.005 [DOI] [PubMed] [Google Scholar]
  • 37.Yang M, Chen P, He MX, Lu M, Wang HM, Soares JC, et al. Poor oral health in patients with schizophrenia: A systematic review and meta-analysis. Schizoph Res. 2018;18:30244 10.1016/j.schres.2018.04.031 [DOI] [PubMed] [Google Scholar]
  • 38.Ajayi DM, Arigbede AO. Barriers to oral health care utilization in Ibadan, South West Nigeria. Afr Health Sci. 2012;12:507–513. 10.4314/ahs.v12i4.17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Mordohai N, Reshad M, Jivraj S, Chee W. Factors that affect individual tooth prognosis and choices in contemporary treatment planning. Br Dent J. 2007;202:63–72. 10.1038/bdj.2007.23 [DOI] [PubMed] [Google Scholar]
  • 40.Dickerson FB, McNary SW, Brown CH, Kreyenbuhl J, Goldberg RW, Dixon LB. Somatic healthcare utilization among adults with serious mental illness who are receiving community psychiatric services. Med Care. 2003;41:560‑70. 10.1097/01.MLR.0000053440.18761.F0 [DOI] [PubMed] [Google Scholar]
  • 41.Samele C, Patel M, Boydell J, Lesse M, Wessely S, Murray R. Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Soc Pychiatry Psychiart Epidemio. 2007;42:117–24. [DOI] [PubMed] [Google Scholar]
  • 42.Heald A. et al. Management of physical health in patients with schizophrenia: practical recommendations. Eur. Psychiatry J. Assoc. Eur. Psychiatr 2010: 25 Suppl 2, S41–45. [DOI] [PubMed] [Google Scholar]
  • 43.Velasco‑Ortega E, Monsalve‑Guil L, Ortiz‑Garcia I, Jimenez‑Guerra A, Lopez‑Lopez J, Segura‑Egea J.J. Dental caries status of patients with schizophrenia in Seville, Spain: a case–control study. BMC Res Notes. 2017; 10:50 10.1186/s13104-016-2368-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Harada S, Akhter R, Kurita K, Mori M, Hoshikoshi M, Tamashiro H, et al. Relationships between lifestyle and dental health behaviors in a rural population in Japan. Community Dent Oral Epidemiol. 2005. February;33(1):17–24. 10.1111/j.1600-0528.2004.00189.x [DOI] [PubMed] [Google Scholar]
  • 45.Ronis DL, Lang WP, Passow E. Tooth brushing, flossing, and preventing dental visits by Detroit‐area residents in relation to demographic and socioeconomic factors. J Public Health Dent 1993; 53: 138–45. 10.1111/j.1752-7325.1993.tb02692.x [DOI] [PubMed] [Google Scholar]
  • 46.Ngo Di Ying Joanna, Thomson W. Murray, Subramaniam Mythily, Abdin Edimansyah, Ang Kok-Yang. The oral health of long-term psychiatric inpatients in Singapore. Psychiatry Research. 2018; 266:206–11. 10.1016/j.psychres.2018.05.048 [DOI] [PubMed] [Google Scholar]
  • 47.Ong G, Yeo JF, Bhole S. A survey of reasons for extraction of permanent teeth in Singapore. Community Dent Oral Epidemiol. 1996. April;24(2):124–7. 10.1111/j.1600-0528.1996.tb00828.x [DOI] [PubMed] [Google Scholar]
  • 48.Petersen PE, Bourgeois D, Bratthall D. Oral health information system–Towards measuring progress in oral health promotion and disease prevention. Bull World Health Organ. 2005;89(9):689–690. [PMC free article] [PubMed] [Google Scholar]
  • 49.Vassos E, Pedersen CB, Murray RM, Collier DA, Lewis CM. Meta-analysis of the association of urbanicity with schizophrenia.Schizophr Bull. 2012;38(6):1118–23. 10.1093/schbul/sbs096 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Vilain J, Galliot AM, Durand-Roger J, Leboyer M, Llorca PM, Schürhoff F, et al. [Environmental risk factors for schizophrenia: a review]. Encephale. 2013. February;39(1):19–28. 10.1016/j.encep.2011.12.007 Epub 2012 Nov 21. [DOI] [PubMed] [Google Scholar]
  • 51.Jongsma HE, Turner C2, Kirkbride JB3, Jones PB. International incidence of psychotic disorders, 2002–17: a systematic review and meta-analysis. Lancet Public Health. 2019. May;4(5):e229–e244. 10.1016/S2468-2667(19)30056-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hiifner H. Nowotny B. Epidemiology of early-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 1995; 245: 80–92. 10.1007/bf02190734 [DOI] [PubMed] [Google Scholar]
  • 53.Marshall M, Rathbone J. Early intervention for psychosis. Cochrane Database Syst Rev. 2006. October 18;(4):CD004718 10.1002/14651858.CD004718.pub2 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Denis Bourgeois

3 Jan 2020

PONE-D-19-20482

Oral health consumption habits of people with schizophrenia in France: a retrospective cohort study

PLOS ONE

Dear Dr. Denis,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Jan 23 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Denis Bourgeois

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

1. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

3. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This submission is about "Oral health habits of people with schizophrenia in Franc"e. This is an analysis of a database dating back to 2014 and which may be considered as irrelevant.

The interest in an international journal is limited as shown in Figures 1-4.

The methodology is not very detailed. Under the term "oral health consumption", the authors select care variables that are not sufficiently descriptive of the accessible dental care panel. Example: "dental treatments"

The discussion is vague and does not concretely answer the objective

The references are not updated and very targeted on France.

Reviewer #2: * This article is well-written and interesting, bringing new knowledge in the epidemiological field of oral health among persons with schizophrenia.

* Title and objective. The term "consumption" might not be relevant for the present study, given that what is measured is more than just "the using up of goods and services". As explained in the introduction, PWS can have difficulties to access to treatment (which is not directly linked to the consumption). Maybe the term "treatment" would be more relevant.

* Introduction section.

- P3, l22 "These factors can include dental caries, periodontal diseases" is unnecessary, since explained factors are related to "dental caries and periodontal measurement indexes (l20).

- P3, l28-31. Please indicate in the text that ref 23 is about PWS.

- P4, l32-33: instead of "on this subject", indicate "on oral health epidemiology".

* Material and methods

- P4, l57: The paragraph should be entitled "Groups constitution", with two clear sub-paragraphs: PWS identification and control identification.

- P5, l70-1: The sentence "Follow-up dental care was explored for all people in the EGB over a period of 3 years (2014 to 2017)" should be placed in the "design of the study and sample of the population" section, because it allows to understand why the study is a retrospective cohort.

-P5, l76: please indicate that these 3 outcomes are covered by French National Insurance

-P5, l81: "The outcomes of interest were explored as qualitative variable" should rather be ""The outcomes of interest were explored as binary (at least one dental treatment) and ordinal qualitative (1,2-3 or >3) variables." Please make the changes in all the manuscript (e.g. p5, l86, etc)

- P5, l87: the Fisher exact test is OK. Pearson χ2 test is not necessary.

- P5, l88: The number and percentage of dental acts were presented ...

- P5-6: "First, PWS were localized according to their place of residence. However, mapping by residence may have compromised patient anonymity in a few cases, so we chose to map according to the department of residence." is OK, but should be removed in the text because it doesn't add meaningful information.

- P6, l96: Paragraph should be entitled "Mapping of population and distribution of dental care" , thus "We mapped the distribution of PWS and the distribution of dental care" l97 should be removed.

- P6, l102: As it is an observational study, authors should be cautious with causation. Thus, it should be written something like " To estimate the association between schizophrenia and dental outcomes, etc..."

*Results

Results are well reported

p7, l137: "confirmed" is not necessary

* Discussion

Discussion is well conducted

-p8, l180, typo "carries"

- Maybe the paragraph p8, l171-177 should appear in the limitation section of the discussion.

Figures

in the legends, please change "à" to "to"

Table 1: Presentation of p-values should be clearer. Readers should easily understand that there are two types of tests in the table (for binary outcomes and qualitative ordinal outcomes)

Table 2: Authors should keep the same definitions in the text and in the table. The labeling of "Persons without schizophrenia" is unclear.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Mar 9;15(3):e0229946. doi: 10.1371/journal.pone.0229946.r002

Author response to Decision Letter 0


17 Feb 2020

Response to reviewers

Reviewer #1:

We thank the Reviewer for giving us an opportunity to substantially improve the content and the presentation of our manuscript. We have modified the article in accordance with your requests. You will find every modification in the text using track changes, and the pages are noted in the answer for every point below. We hope we have met your requirements to improve this paper.

This submission is about "Oral health habits of people with schizophrenia in France". This is an analysis of a database dating back to 2014 and which may be considered as irrelevant.

Response: Please consider that this retrospective study explored a follow-up dental care for a period of 3 years (2014 to 2017) for persons with schizophrenia.

The interest in an international journal is limited as shown in Figures 1-4.

The methodology is not very detailed. Under the term "oral health consumption", the authors select care variables that are not sufficiently descriptive of the accessible dental care panel. Example: "dental treatments"

Response:

We thank the Reviewer for this comment. We completed the definition of the procedures and added some examples.

In Methods section, page 5, lines 84-87:

2) Dental treatments were all procedures for filling cavities, root canal treatments, such as exeresis of canal content or exeresis of pulp, tooth restoration, and denture repair.

3) Tooth extractions were identified by their location in the mouth, i.e. avulsion of canine tooth, ectopic tooth, or molar tooth.

The discussion is vague and does not concretely answer the objective

Response: We agree with the Reviewer that the discussion needed to be revised. In particular, the first paragraph was rather vague and did not provide the main results of our paper regarding our objective. This paragraph was rewritten accordingly.

The references are not updated and very targeted on France.

Response: We thank the reviewer for this relevant comment.

We agree that our references were very targeted on France. In fact, the most recent available data on this subject on oral health epidemiology in France for the general population are more than 20 years old, except for the following reference that we included in our paper.

[15]-Bertaud-Gounot V, Kovess-Masfety V, Perrus C, Trohel G, Richard F. Oral health status and treatment needs among psychiatric inpatients in Rennes, France: a cross-sectional study. BMC Psychiatry 2013, 13:227

We also included references regarding other countries:

[46]-Di Ying Joanna Ngo, W. Murray Thomson, Mythily Subramaniam, Edimansyah Abdin,Kok-Yang Ang. The oral health of long-term psychiatric inpatients in Singapore. Psychiatry Research. 2018; 266:206-11.

[43]-Velasco‑Ortega E, Monsalve‑Guil L, Ortiz‑Garcia I, Jimenez‑Guerra A, Lopez‑Lopez J, Segura‑Egea J.J. Dental caries status of patients with schizophrenia in Seville, Spain: a case–control study. BMC Res Notes (2017) 10:50

[34]-Chu, K.-Y., Yang, N.-P., Chou, P., Chiu, H.-J., Chi, L.-Y., 2012. Comparison of oral health between

inpatients with schizophrenia and disabled people or the general population. J. Formos. Med. Assoc. 111 (4), 214–219.

[19]-Ramon, T., Grinshpoon, A., Zusman, S., Weizman, A., 2003. Oral health and treatment

needs of institutionalized chronic psychiatric patients in Israel. Eur. Psychiatry 18 (3), 101–105.

Reviewer #2:

1-This article is well-written and interesting, bringing new knowledge in the epidemiological field of oral health among persons with schizophrenia.

Response: We thank the Reviewer for giving us an opportunity to substantially improve the content and the presentation of our manuscript. We have modified the article in accordance with your requests. You will find every modification in the text using track changes, and the pages are noted in the answer for every point below. We hope we have met your requirements to improve this paper.

2-Title and objective. The term "consumption" might not be relevant for the present study, given that what is measured is more than just "the using up of goods and services". As explained in the introduction, PWS can have difficulties to access to treatment (which is not directly linked to the consumption). Maybe the term "treatment" would be more relevant.

Response: We have changed this term as requested throughout the manuscript.

* Introduction section.

3- P3, l22 "These factors can include dental caries, periodontal diseases" is unnecessary, since explained factors are related to "dental caries and periodontal measurement indexes (l20).

Response: We have deleted this sentence.

4- P3, l28-31. Please indicate in the text that ref 23 is about PWS.

Response: We made this correction in the text of the paper (page 3, line 30).

5- P4, l32-33: instead of "on this subject", indicate "on oral health epidemiology".

Response: This correction has been made (page 4, line 34).

* Material and methods

6- P4, l57: The paragraph should be entitled "Groups constitution", with two clear sub-paragraphs: PWS identification and control identification.

Response: We thank the reviewer for this suggestion and modified this paragraph accordingly.

7- P5, l70-1: The sentence "Follow-up dental care was explored for all people in the EGB over a period of 3 years (2014 to 2017)" should be placed in the "design of the study and sample of the population" section, because it allows to understand why the study is a retrospective cohort.

Response: We agree with the Reviewer. This correction was made (page 4, lines 43-44).

8-P5, l76: please indicate that these 3 outcomes are covered by French National Insurance

Response: Done (page 5, line 81).

9-P5, l81: "The outcomes of interest were explored as qualitative variable" should rather be ""The outcomes of interest were explored as binary (at least one dental treatment) and ordinal qualitative (1,2-3 or >3) variables." Please make the changes in all the manuscript (e.g. p5, l86, etc)

Response: We thank the Reviewer for this comment.

We made a mistake in the manuscript: the variables with several categories (1, 2-3 or >3) were considered as qualitative variables, and not as quantitative variables. The outcomes of interest were explored as qualitative nominal variables (binary or > 2 levels). We don’t consider the variables > 2 categories as ordinal qualitative variables. We have clarified this point in the method section.

Page 5, lines 88-90: “The outcomes of interest were explored as qualitative variables: binary (at least one dental treatment) or nominal variables with more than 2 categories (1, 2-3 or >3).”

10- P5, l87: the Fisher exact test is OK. Pearson χ2 test is not necessary.

Response: We agree, we deleted “Pearson χ2 test” in the sentence.

11- P5, l88: The number and percentage of dental acts were presented ...

We thank the Reviewer for this suggestion. We modified the sentence accordingly:

Page 6, lines 96-97 “The number and percentage of dental acts were presented by class (1, 2-3, or >3) for each type of care.”

12- P5-6: "First, PWS were localized according to their place of residence. However, mapping by residence may have compromised patient anonymity in a few cases, so we chose to map according to the department of residence." is OK, but should be removed in the text because it doesn't add meaningful information.

Response: This correction was made

13- P6, l96: Paragraph should be entitled "Mapping of population and distribution of dental care" , thus "We mapped the distribution of PWS and the distribution of dental care" l97 should be removed.

Response: This correction was made.

14- P6, l102: As it is an observational study, authors should be cautious with causation. Thus, it should be written something like " To estimate the association between schizophrenia and dental outcomes, etc..."

Response: We thank the Reviewer for this comment. We have made the change as requested (page 6, line 111).

*Results: Results are well reported

15- p7, l137: "confirmed" is not necessary

Response: We deleted “confirmed” as requested

* Discussion: Discussion is well conducted

16 -p8, l180, typo "carries"

Response: Thank you for pointing this error which was corrected.

17- Maybe the paragraph p8, l171-177 should appear in the limitation section of the discussion.

Response: We agree with this suggestion. We moved this sentence from the beginning of the “discussion” section to the” limitation” subsection (page 12, lines 294-300).

Figures

18-in the legends, please change "à" to "to"

Response: Thank you for pointing this error which was corrected.

19-Table 1: Presentation of p-values should be clearer. Readers should easily understand that there are two types of tests in the table (for binary outcomes and qualitative ordinal outcomes).

As mentioned before, we have considered all the variables as qualitative nominal variables. We have used the Pearson Chi² test or the Fisher exact test, under the conditions of application. The Fischer exact test was added in the table, as you indicated that the Pearson Chi² test was not necessary.

20-Table 2: Authors should keep the same definitions in the text and in the table. The labeling of "Persons without schizophrenia" is unclear.

Response: We agree with this suggestion. We removed "Persons without schizophrenia” and have replaced it by “Control Group”.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Denis Bourgeois

19 Feb 2020

Oral health treatment habits of people with schizophrenia in France: a retrospective cohort study

PONE-D-19-20482R1

Dear Dr. Denis,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Denis Bourgeois

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Denis Bourgeois

21 Feb 2020

PONE-D-19-20482R1

Oral health treatment habits of people with schizophrenia in France: a retrospective cohort study

Dear Dr. Denis:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Denis Bourgeois

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    The database was transmitted by the National Health Insurance Fund for Salaried Workers-CNAMTS (Caisse nationale de l'assurance maladie des travailleurs salaries; address: Caisse Nationale de l’Assurance Maladie 50 Avenue du Professeur André Lemierre, 75020 Paris) (responsible for the extraction of EGB data). The use of these data by our department was approved by the National Committee for data protection. Data used in this study are available for researchers who meet the criteria for access to these French data from the National Health Insurance Fund (training that open a personal accreditation, approval of the protocol by required authorities (Expert Committee to researches, studies and evaluations in the health field-CEREES, and National Committee for data protection-CNIL) according to the “Décret n° 2016-1872 du 26 décembre 2016 modifiant le décret n° 2005-1309 du 20 octobre 2005 pris pour l’application de la loi n° 78-17 du 6 janvier 1978 relative à l’informatique, aux fichiers et aux libertés”, https://www.legifrance.gouv.fr/eli/decret/2016/12/26/2016-1872/jo/texte. A permanent access is granted to some public services within the limits established by laws (Décret n° 2016-1871 du 26 décembre 2016 relatif au traitement de données à caractère personnel dénommé « système national des données de santé », https://www.legifrance.gouv.fr/eli/decret/2016/12/26/2016-1871/jo/texte. Contact: Caisse Nationale de l’Assurance Maladie, 50 Avenue du Professeur André Lemierre, 75020 Paris


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES